| Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial. J Armitage, L Bowman, K Wallendszus, R Bulbulia, K Rahimi, R Haynes, ... Lancet (London, England) 376 (9753), 2010 | 533 | 2010 |
| Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial T Crosby, CN Hurt, S Falk, S Gollins, S Mukherjee, J Staffurth, R Ray, ... The lancet oncology 14 (7), 627-637, 2013 | 429 | 2013 |
| Risk of adverse birth outcomes in populations living near landfill sites P Elliott, D Briggs, S Morris, C de Hoogh, C Hurt, TK Jensen, I Maitland, ... Bmj 323 (7309), 363-368, 2001 | 412 | 2001 |
| Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial S Mukherjee, CN Hurt, J Bridgewater, S Falk, S Cummins, H Wasan, ... The lancet oncology 14 (4), 317-326, 2013 | 391 | 2013 |
| PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive … W Owadally, C Hurt, H Timmins, E Parsons, S Townsend, J Patterson, ... BMC cancer 15, 1-10, 2015 | 222 | 2015 |
| Definitive chemoradiation for oesophageal cancer—a standard of care in patients with non-metastatic oesophageal cancer S Gwynne, C Hurt, M Evans, C Holden, L Vout, T Crosby Clinical Oncology 23 (3), 182-188, 2011 | 133 | 2011 |
| Aetiology of stillbirths and neonatal deaths in rural Ghana: implications for health programming in developing countries KM Edmond, MA Quigley, C Zandoh, S Danso, C Hurt, SO Agyei, ... Paediatric and perinatal epidemiology 22 (5), 430-437, 2008 | 133 | 2008 |
| Effect of vitamin A supplementation in women of reproductive age on maternal survival in Ghana (ObaapaVitA): a cluster-randomised, placebo-controlled trial BR Kirkwood, L Hurt, S Amenga-Etego, C Tawiah, C Zandoh, S Danso, ... The Lancet 375 (9726), 1640-1649, 2010 | 127 | 2010 |
| Cancer risks in populations living near landfill sites in Great Britain L Jarup, D Briggs, C De Hoogh, S Morris, C Hurt, A Lewin, I Maitland, ... British journal of cancer 86 (11), 1732-1736, 2002 | 111 | 2002 |
| Role of nutritional status and intervention in oesophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1 S Cox, C Powell, B Carter, C Hurt, S Mukherjee, TDL Crosby British journal of cancer 115 (2), 172-177, 2016 | 110 | 2016 |
| Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT3VIN): a multicentre, open-label, randomised, phase 2 trial A Tristram, CN Hurt, T Madden, N Powell, S Man, S Hibbitts, P Dutton, ... The Lancet Oncology 15 (12), 1361-1368, 2014 | 106 | 2014 |
| Mitochondria death/survival signaling pathways in cardiotoxicity induced by anthracyclines and anticancer-targeted therapies D Montaigne, C Hurt, R Neviere Biochemistry research international 2012, 2012 | 98 | 2012 |
| Diagnostic accuracy of verbal autopsies in ascertaining the causes of stillbirths and neonatal deaths in rural Ghana KM Edmond, MA Quigley, C Zandoh, S Danso, C Hurt, SO Agyei, ... Paediatric and perinatal epidemiology 22 (5), 417-429, 2008 | 93 | 2008 |
| Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised … JH Beigel, Y Bao, J Beeler, W Manosuthi, A Slandzicki, SM Dar, J Panuto, ... The Lancet infectious diseases 17 (12), 1255-1265, 2017 | 87 | 2017 |
| Effect of early neonatal vitamin A supplementation on mortality during infancy in Ghana (Neovita): a randomised, double-blind, placebo-controlled trial KM Edmond, S Newton, C Shannon, M O'Leary, L Hurt, G Thomas, ... The Lancet 385 (9975), 1315-1323, 2015 | 79 | 2015 |
| Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy+/− cetuximab in oesophageal cancer T Crosby, CN Hurt, S Falk, S Gollins, J Staffurth, R Ray, JA Bridgewater, ... British journal of cancer 116 (6), 709-716, 2017 | 76 | 2017 |
| Evidence-based guidelines and decision support services: a discussion and evaluation in triple assessment of suspected breast cancer V Patkar, C Hurt, R Steele, S Love, A Purushotham, M Williams, ... British Journal of Cancer 95 (11), 1490-1496, 2006 | 73 | 2006 |
| SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus CN Hurt, LS Nixon, GO Griffiths, R Al-Mokhtar, S Gollins, JN Staffurth, ... BMC cancer 11, 1-11, 2011 | 69 | 2011 |
| Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine-or capecitabine-based chemoradiation for locally advanced pancreatic cancer CN Hurt, S Falk, T Crosby, A McDonald, R Ray, G Joseph, J Staffurth, ... British journal of cancer 116 (10), 1264-1270, 2017 | 65 | 2017 |
| Prospective patient stratification into robust cancer‐cell intrinsic subtypes from colorectal cancer biopsies M Alderdice, SD Richman, S Gollins, JP Stewart, C Hurt, R Adams, ... The Journal of pathology 245 (1), 19-28, 2018 | 64 | 2018 |
